Form 4: CME Group Director Receives Stock Grant

Martin J. Gepsman, a Director at CME Group Inc., received a grant of 645 fully vested shares of Class A Common Stock as part of the company's annual equity compensation program.

Summary

• Director Martin J. Gepsman was granted 645 shares of Class A Common Stock on June 25, 2026.
• These shares were issued as part of CME Group's annual equity compensation program for non-employee directors.
• The shares are fully vested and not subject to any further vesting conditions.
• Following this transaction, Gepsman beneficially owns 25,644 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine compensation event for a director rather than a significant strategic or financial development.

Positives

• Director compensation aligns with equity ownership, potentially aligning incentives.
• Grant of fully vested shares indicates immediate value recognition for the director's service.
• The transaction is part of a standard annual compensation program, suggesting predictable executive compensation practices.

Future Outlook

This filing pertains to a past transaction and does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that the issuance of stock grants to directors is a common practice in the financial services and exchange industry, aimed at retaining talent and aligning executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The grant of stock to directors is a standard compensation practice and does not immediately impact share price, but it does dilute ownership slightly over time as part of compensation.

Key Dates

Keywords

CME Group, Director Stock Grant, Equity Compensation, Form 4, Insider Trading, Beneficial Ownership, Class A Common Stock